We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+0.29%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$16.3B
AUM Growth
-$605M
(-3.6%)
Cap. Flow
-$575M
Cap. Flow
% of AUM
-3.52%
Top 10 Holdings %
Top 10 Hldgs %
31.59%
Holding
665
New
90
Increased
197
Reduced
206
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$135M |
| 2 |
Merck
MRK
|
+$129M |
| 3 |
US Bancorp
USB
|
+$91.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$84.2M |
| 5 |
Elevance Health
ELV
|
+$72.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$185M |
| 2 |
AABA
Altaba Inc
AABA
|
+$138M |
| 3 |
Alibaba
BABA
|
+$112M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$87.5M |
| 5 |
Humana
HUM
|
+$87.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.1% |
| 2 | Healthcare | 18.77% |
| 3 | Financials | 10.98% |
| 4 | Communication Services | 9.03% |
| 5 | Consumer Discretionary | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
576
Chimera Investment
CIM
$1.06B
| – | – |
-4,067
| Closed | -$225K |
|
577
Canadian Imperial Bank of Commerce
CM
$108B
| – | – |
-5,600
| Closed | -$274K |
|
578
Conduent
CNDT
$245M
| – | – |
-18,700
| Closed | -$302K |
|
579
Canadian National Railway
CNI
$76.9B
| – | – |
-38,240
| Closed | -$3.16M |
|
580
Charles River Laboratories
CRL
$11.3B
| – | – |
-3,500
| Closed | -$383K |
|
581
CVS Health
CVS
$134B
| – | – |
-1,058,311
| Closed | -$75.9M |
|
582
Chevron
CVX
$383B
| – | – |
-68,293
| Closed | -$8.55M |
|
|
CWEN.A
583
DELISTED
Clearway Energy Class A
CWEN.A
| – | – |
-17,300
| Closed | -$326K |
|
584
Cemex
CX
$17.2B
| – | – |
-5,551,333
| Closed | -$41.6M |
|
585
Community Health Systems
CYH
$391M
| – | – |
-66,300
| Closed | -$282K |
|
586
Darden Restaurants
DRI
$23.7B
| – | – |
-2,200
| Closed | -$211K |
|
587
Everest Group
EG
$14.5B
| – | – |
-1,400
| Closed | -$310K |
|
588
Edison International
EIX
$30.3B
| – | – |
-104,500
| Closed | -$6.61M |
|
589
Enovis
ENOV
$1.69B
| – | – |
-10,574
| Closed | -$721K |
|
590
Essent Group
ESNT
$6.12B
| – | – |
-6,500
| Closed | -$282K |
|
591
Entergy
ETR
$50.4B
| – | – |
-199,600
| Closed | -$8.12M |
|
592
FirstEnergy
FE
$28.2B
| – | – |
-254,900
| Closed | -$7.8M |
|
593
Flexsteel Industries
FLXS
$301M
| – | – |
-4,295
| Closed | -$201K |
|
594
Greif
GEF
$4.96B
| – | – |
-5,000
| Closed | -$303K |
|
595
Gen Digital
GEN
$16.3B
| – | – |
-36,300
| Closed | -$1.02M |
|
596
CGI
GIB
$15.2B
| – | – |
-7,000
| Closed | -$382K |
|
597
Gran Tierra Energy
GTE
$237M
| – | – |
-12,222
| Closed | -$330K |
|
598
Innoviva
INVA
$1.57B
| – | – |
-14,600
| Closed | -$207K |
|
599
Intrepid Potash
IPI
$474M
| – | – |
-1,490
| Closed | -$71K |
|
600
John B. Sanfilippo & Son
JBSS
$954M
| – | – |
-4,950
| Closed | -$313K |
|
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2018 Portfolio in Review
As of Q1 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 665 positions worth $16.3B, down 3.6% from $17B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $575M in Q1 2018, closing 98 positions and reducing 206 holdings. Its most notable exit was CVS Health, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Meta Platforms (Facebook) worth $120M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2018 buy was Meta Platforms (Facebook): 752,487 shares worth $120M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Merck in Q1 2018, an estimated $129M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2018 reduction was Microsoft, cutting an estimated $185M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited CVS Health in Q1 2018, selling an estimated $75.9M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 32% of its $16.3B portfolio in Q1 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 90 new positions and closed 98 in Q1 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 3.6% quarter-over-quarter to $16.3B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2018, filed 15 May 2018.